|
Eli Lilly and Company
LLY
|
$ 733.51
|
$ 660 B
|
$ 3.05 B
|
116.1
|
16.5
|
$ 5.0
|
|
|
Novo Nordisk A/S
NVO
|
$ 126.85
|
$ 421 B
|
∙ |
∙ |
∙ |
∙ |
|
|
Merck & Co.
MRK
|
$ 131.2
|
$ 333 B
|
$ 3.41 B
|
54.1
|
4.3
|
$ 1.9
|
|
|
Nanobiotix S.A.
NBTX
|
$ 5.74
|
$ 286 B
|
∙ |
∙ |
∙ |
∙ |
|
|
AbbVie
ABBV
|
$ 159.62
|
$ 282 B
|
$ 14.9 B
|
31.4
|
4.6
|
$ 4.5
|
|
|
Novartis AG
NVS
|
$ 97.44
|
$ 227 B
|
$ 10.7 B
|
14.3
|
∙ |
$ 5.8
|
|
|
Genfit SA
GNFT
|
$ 3.49
|
$ 160 B
|
∙ |
∙ |
∙ |
∙ |
|
|
Pfizer
PFE
|
$ 25.4
|
$ 143 B
|
$ 9.62 B
|
12.2
|
2.6
|
$ 2.5
|
|
|
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 397.48
|
$ 102 B
|
$ 4.24 B
|
27.3
|
10.0
|
$ 13.9
|
|
|
AstraZeneca PLC
AZN
|
$ 75.17
|
$ 96.9 B
|
$ 3.67 B
|
47.0
|
7.9
|
$ 1.4
|
|
|
Regeneron Pharmaceuticals
REGN
|
$ 883.2
|
$ 94.2 B
|
$ 4.95 B
|
21.3
|
7.0
|
$ 38.5
|
|
|
Gilead Sciences
GILD
|
$ 65.42
|
$ 81.6 B
|
$ 10.6 B
|
16.7
|
3.7
|
$ 4.8
|
|
|
Zoetis
ZTS
|
$ 158.42
|
$ 73.1 B
|
$ 480 M
|
31.8
|
9.0
|
$ 5.1
|
|
|
Alexion Pharmaceuticals, Inc.
ALXN
|
$ 182.5
|
$ 40.3 B
|
$ 33.9 M
|
∙ |
∙ |
∙ |
|
|
BioNTech SE
BNTX
|
$ 87.21
|
$ 27.2 B
|
∙ |
∙ |
∙ |
∙ |
|
|
argenx SE
ARGX
|
$ 372.8
|
$ 25 B
|
∙ |
∙ |
∙ |
∙ |
|
|
Axon Enterprise
AXON
|
$ 308.23
|
$ 22.9 B
|
$ 112 M
|
124.2
|
10.7
|
$ 1.8
|
|
|
Legend Biotech Corporation
LEGN
|
$ 45.3
|
$ 18.7 B
|
∙ |
∙ |
∙ |
∙ |
|
|
Genmab A/S
GMAB
|
$ 28.15
|
$ 18.6 B
|
$ 5.56 B
|
0.6
|
2.7
|
$ 62.2
|
|
|
BioMarin Pharmaceutical
BMRN
|
$ 80.91
|
$ 15.2 B
|
$ 196 M
|
107.7
|
6.5
|
$ 0.7
|
|
|
Neurocrine Biosciences
NBIX
|
$ 135.99
|
$ 13.3 B
|
$ 50 M
|
63.0
|
6.0
|
$ 1.8
|
|
|
Royalty Pharma plc
RPRX
|
$ 28.0
|
$ 12.5 B
|
$ 1.1 B
|
15.8
|
5.2
|
$ 1.8
|
|
|
Incyte Corporation
INCY
|
$ 51.68
|
$ 11.6 B
|
$ 619 M
|
23.6
|
3.4
|
$ 2.3
|
|
|
United Therapeutics Corporation
UTHR
|
$ 233.85
|
$ 10.9 B
|
$ 1.15 B
|
10.3
|
4.6
|
$ 21.7
|
|
|
Acceleron Pharma Inc.
XLRN
|
$ 179.68
|
$ 10.9 B
|
$ -60.9 M
|
∙ |
∙ |
∙ |
|
|
Bio-Techne Corporation
TECH
|
$ 64.06
|
$ 10.1 B
|
$ 413 M
|
∙ |
∙ |
∙ |
|
|
Институт стволовых клеток человека
ISKJ
|
-
|
-
|
₽ -3.4 M
|
∙ |
∙ |
∙ |
|
|
Pharming Group N.V.
PHAR
|
$ 9.8
|
$ 7.59 B
|
∙ |
∙ |
∙ |
∙ |
|
|
Exelixis
EXEL
|
$ 23.7
|
$ 7.54 B
|
$ 314 M
|
∙ |
3.8
|
∙ |
|
|
Jazz Pharmaceuticals plc
JAZZ
|
$ 109.46
|
$ 6.93 B
|
$ 937 M
|
27.1
|
2.1
|
$ 4.7
|
|
|
Alterity Therapeutics Limited
ATHE
|
$ 2.49
|
$ 5.99 B
|
∙ |
∙ |
∙ |
∙ |
|
|
Halozyme Therapeutics
HALO
|
$ 38.57
|
$ 5.09 B
|
$ 330 M
|
18.3
|
6.0
|
$ 1.9
|
|
|
Abcam plc
ABCM
|
$ 23.99
|
$ 4.9 B
|
∙ |
∙ |
∙ |
∙ |
|
|
Aphria Inc.
APHA
|
$ 15.38
|
$ 4.87 B
|
$ 2.32 B
|
∙ |
∙ |
∙ |
|
|
China Biologic Products Holdings, Inc.
CBPO
|
$ 119.99
|
$ 4.65 B
|
$ 991 M
|
∙ |
∙ |
∙ |
|
|
Alkermes plc
ALKS
|
$ 24.68
|
$ 4.1 B
|
$ 221 M
|
21.7
|
2.5
|
$ 1.1
|
|
|
Gracell Biotechnologies
GRCL
|
$ 10.25
|
$ 3.37 B
|
∙ |
∙ |
∙ |
∙ |
|
|
Immunovant
IMVT
|
$ 27.17
|
$ 3.34 B
|
$ 324 K
|
∙ |
∙ |
∙ |
|
|
Axsome Therapeutics
AXSM
|
$ 71.71
|
$ 3.26 B
|
$ -203 M
|
∙ |
∙ |
∙ |
|
|
Dicerna Pharmaceuticals, Inc.
DRNA
|
$ 38.25
|
$ 2.98 B
|
$ -70.6 M
|
∙ |
∙ |
∙ |
|
|
Viela Bio, Inc.
VIE
|
$ 53.01
|
$ 2.91 B
|
$ 57.6 M
|
∙ |
∙ |
∙ |
|
|
Translate Bio, Inc.
TBIO
|
$ 37.36
|
$ 2.81 B
|
$ 86.2 M
|
∙ |
∙ |
∙ |
|
|
Burford Capital Limited
BUR
|
$ 15.39
|
$ 2.67 B
|
∙ |
∙ |
∙ |
∙ |
|
|
BELLUS Health
BLU
|
$ 14.74
|
$ 2.47 B
|
∙ |
∙ |
∙ |
∙ |
|
|
Can-Fite BioPharma Ltd.
CANF
|
$ 1.93
|
$ 2.47 B
|
∙ |
∙ |
∙ |
∙ |
|
|
Arrowhead Pharmaceuticals
ARWR
|
$ 22.12
|
$ 2.36 B
|
$ -222 M
|
∙ |
∙ |
∙ |
|
|
Corcept Therapeutics Incorporated
CORT
|
$ 22.8
|
$ 2.36 B
|
$ 106 M
|
26.8
|
6.7
|
$ 1.0
|
|
|
PTC Therapeutics
PTCT
|
$ 28.57
|
$ 2.14 B
|
$ -287 M
|
∙ |
∙ |
∙ |
|
|
Outlook Therapeutics
OTLK
|
$ 8.43
|
$ 2.11 B
|
$ -91.9 M
|
∙ |
∙ |
∙ |
|
|
Trillium Therapeutics Inc.
TRIL
|
$ 18.44
|
$ 1.94 B
|
$ 3.56 M
|
∙ |
∙ |
∙ |
|
|
Pandion Therapeutics, Inc.
PAND
|
$ 60.05
|
$ 1.77 B
|
∙ |
∙ |
∙ |
∙ |
|
|
Five Prime Therapeutics, Inc.
FPRX
|
$ 38.0
|
$ 1.77 B
|
$ 17.3 M
|
∙ |
∙ |
∙ |
|
|
Harmony Biosciences Holdings
HRMY
|
$ 29.32
|
$ 1.74 B
|
$ 182 M
|
7.4
|
2.6
|
$ 3.2
|
|
|
Sana Biotechnology
SANA
|
$ 8.72
|
$ 1.7 B
|
$ -271 M
|
∙ |
∙ |
∙ |
|
|
Kadmon Holdings, Inc.
KDMN
|
$ 9.5
|
$ 1.7 B
|
∙ |
∙ |
∙ |
∙ |
|
|
Constellation Pharmaceuticals, Inc.
CNST
|
$ 33.99
|
$ 1.63 B
|
$ -14 M
|
∙ |
∙ |
∙ |
|
|
Catalyst Pharmaceuticals
CPRX
|
$ 14.89
|
$ 1.58 B
|
$ 107 M
|
22.1
|
3.8
|
$ 0.6
|
|
|
Завод ДИОД
DIOD
|
-
|
-
|
₽ 39.9 M
|
∙ |
∙ |
∙ |
|
|
Фармсинтез
LIFE
|
-
|
-
|
∙ |
∙ |
∙ |
∙ |
|
|
Dynavax Technologies Corporation
DVAX
|
$ 11.21
|
$ 1.44 B
|
$ 195 M
|
31.3
|
5.2
|
$ 0.4
|
|
|
Adaptimmune Therapeutics plc
ADAP
|
$ 1.08
|
$ 1.3 B
|
$ -128 M
|
∙ |
8.1
|
∙ |
|
|
Ligand Pharmaceuticals Incorporated
LGND
|
$ 70.57
|
$ 1.22 B
|
$ 128 M
|
27.1
|
5.7
|
$ 2.0
|
|
|
Opthea Limited
OPT
|
$ 3.4
|
$ 1.2 B
|
∙ |
∙ |
∙ |
∙ |
|
|
Morphic Holding
MORF
|
$ 28.07
|
$ 1.19 B
|
$ -96.7 M
|
∙ |
∙ |
∙ |
|
|
Immutep Limited
IMMP
|
$ 2.65
|
$ 1.08 B
|
∙ |
∙ |
∙ |
∙ |
|
|
Maravai LifeSciences Holdings
MRVI
|
$ 7.7
|
$ 1.02 B
|
$ 103 M
|
∙ |
1.5
|
∙ |
|
|
Innoviva
INVA
|
$ 15.26
|
$ 999 M
|
$ 284 M
|
2.2
|
3.0
|
$ 5.6
|
|
|
Cassava Sciences
SAVA
|
$ 22.34
|
$ 937 M
|
$ -104 M
|
∙ |
22.7
|
∙ |
|
|
MacroGenics
MGNX
|
$ 14.56
|
$ 902 M
|
$ -152 M
|
27.3
|
3.7
|
$ 0.2
|
|
|
Zealand Pharma A/S
ZEAL
|
$ 17.47
|
$ 821 M
|
$ -348 M
|
∙ |
12.4
|
∙ |
|
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
$ 1.36
|
$ 768 M
|
∙ |
22.3
|
∙ |
$ 0.1
|
|
|
Nurix Therapeutics
NRIX
|
$ 12.36
|
$ 672 M
|
$ -174 M
|
∙ |
∙ |
∙ |
|
|
Zogenix, Inc.
ZGNX
|
$ 11.85
|
$ 664 M
|
$ 23.7 M
|
∙ |
∙ |
∙ |
|
|
Mereo BioPharma Group plc
MREO
|
$ 2.74
|
$ 660 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Catabasis Pharmaceuticals, Inc.
CATB
|
$ 8.54
|
$ 657 M
|
$ 9.44 B
|
∙ |
∙ |
∙ |
|
|
Intercept Pharmaceuticals
ICPT
|
$ 19.0
|
$ 643 M
|
$ -80.6 M
|
2.8
|
2.0
|
$ 6.8
|
|
|
SIGA Technologies
SIGA
|
$ 8.79
|
$ 627 M
|
$ 43 M
|
13.2
|
3.9
|
$ 0.4
|
|
|
Silence Therapeutics plc
SLN
|
$ 21.61
|
$ 622 M
|
∙ |
∙ |
∙ |
∙ |
|
|
89bio
ETNB
|
$ 8.26
|
$ 588 M
|
$ -105 M
|
∙ |
∙ |
∙ |
|
|
Urovant Sciences Ltd.
UROV
|
$ 16.24
|
$ 532 M
|
$ 2.76 B
|
∙ |
∙ |
∙ |
|
|
Frequency Therapeutics
FREQ
|
$ 14.98
|
$ 528 M
|
$ -62.7 M
|
∙ |
∙ |
∙ |
|
|
Theravance Biopharma
TBPH
|
$ 9.12
|
$ 504 M
|
$ -131 M
|
0.9
|
14.3
|
$ 11.3
|
|
|
MediWound Ltd.
MDWD
|
$ 18.24
|
$ 496 M
|
$ -42.7 M
|
∙ |
∙ |
∙ |
|
|
Avid Bioservices
CDMO
|
$ 7.35
|
$ 458 M
|
$ -4.52 M
|
∙ |
∙ |
∙ |
|
|
XTL Biopharmaceuticals Ltd.
XTLB
|
$ 2.4
|
$ 442 M
|
$ -520 K
|
∙ |
∙ |
∙ |
|
|
Replimune Group
REPL
|
$ 6.42
|
$ 374 M
|
$ -215 M
|
∙ |
∙ |
∙ |
|
|
Precigen
PGEN
|
$ 1.41
|
$ 345 M
|
$ 14.9 M
|
7.0
|
∙ |
$ 0.2
|
|
|
I-Mab
IMAB
|
$ 1.8
|
$ 342 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Voyager Therapeutics
VYGR
|
$ 7.62
|
$ 328 M
|
$ 106 M
|
2.7
|
1.2
|
$ 2.4
|
|
|
Trean Insurance Group
TIG
|
$ 6.16
|
$ 316 M
|
$ 6 M
|
9.7
|
1.2
|
$ 0.6
|
|
|
Cerecor Inc.
CERC
|
$ 2.93
|
$ 283 M
|
$ 174 M
|
∙ |
∙ |
∙ |
|
|
Anavex Life Sciences Corp.
AVXL
|
$ 3.44
|
$ 274 M
|
$ -51.1 M
|
∙ |
∙ |
∙ |
|
|
ESSA Pharma
EPIX
|
$ 6.08
|
$ 268 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Vanda Pharmaceuticals
VNDA
|
$ 4.62
|
$ 265 M
|
$ -1.52 M
|
∙ |
0.9
|
∙ |
|
|
ZIOPHARM Oncology, Inc.
ZIOP
|
$ 1.22
|
$ 264 M
|
$ 154 M
|
∙ |
∙ |
∙ |
|
|
Kamada Ltd.
KMDA
|
$ 5.15
|
$ 260 M
|
$ 6.96 M
|
32.8
|
3.3
|
$ 0.1
|
|
|
BioDelivery Sciences International
BDSI
|
$ 2.58
|
$ 255 M
|
$ 40.6 M
|
8.3
|
1.5
|
$ 0.3
|
|
|
MorphoSys AG
MOR
|
$ 18.04
|
$ 254 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Chiasma, Inc.
CHMA
|
$ 3.76
|
$ 238 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Puma Biotechnology
PBYI
|
$ 5.02
|
$ 237 M
|
$ 23.5 M
|
13.1
|
0.5
|
$ 0.2
|
|
|
Innate Pharma S.A.
IPHA
|
$ 2.46
|
$ 235 M
|
∙ |
∙ |
∙ |
∙ |
|
|
AC Immune SA
ACIU
|
$ 2.35
|
$ 229 M
|
$ -49.6 M
|
∙ |
28.0
|
∙ |
|
|
KalVista Pharmaceuticals
KALV
|
$ 10.78
|
$ 206 M
|
$ -108 M
|
∙ |
∙ |
∙ |
|
|
Biophytis SA
BPTS
|
$ 8.22
|
$ 169 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Compugen Ltd.
CGEN
|
$ 1.92
|
$ 168 M
|
∙ |
∙ |
8.9
|
∙ |
|
|
Progenity, Inc.
PROG
|
$ 0.88
|
$ 164 M
|
∙ |
∙ |
∙ |
∙ |
|
|
La Jolla Pharmaceutical Company
LJPC
|
$ 6.2
|
$ 154 M
|
$ 1.73 M
|
9.0
|
3.1
|
$ 0.7
|
|
|
Inventiva S.A.
IVA
|
$ 3.25
|
$ 138 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Rezolute
RZLT
|
$ 2.66
|
$ 136 M
|
$ -65.1 M
|
∙ |
∙ |
∙ |
|
|
Strongbridge Biopharma plc
SBBP
|
$ 2.0
|
$ 136 M
|
$ 1.52 B
|
∙ |
∙ |
∙ |
|
|
Repare Therapeutics
RPTX
|
$ 3.2
|
$ 135 M
|
$ -32.4 M
|
15.7
|
∙ |
$ 0.2
|
|
|
Adagene
ADAG
|
$ 2.43
|
$ 133 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Acasti Pharma
ACST
|
$ 2.9
|
$ 129 M
|
$ -18.2 M
|
∙ |
∙ |
∙ |
|
|
Corner Growth Acquisition Corp.
COOL
|
$ 11.34
|
$ 117 M
|
$ -2.59 M
|
∙ |
∙ |
∙ |
|
|
Oncolytics Biotech
ONCY
|
$ 1.09
|
$ 115 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Biofrontera AG
BFRA
|
$ 3.45
|
$ 105 M
|
$ -196 M
|
∙ |
∙ |
∙ |
|
|
Aerpio Pharmaceuticals, Inc.
ARPO
|
$ 2.2
|
$ 104 M
|
$ 12.1 M
|
∙ |
∙ |
∙ |
|
|
Citius Pharmaceuticals
CTXR
|
$ 0.66
|
$ 99.9 M
|
$ -51.3 M
|
∙ |
∙ |
∙ |
|
|
Heat Biologics, Inc.
HTBX
|
$ 3.93
|
$ 99.8 M
|
$ 2.9 M
|
∙ |
∙ |
∙ |
|
|
Oramed Pharmaceuticals
ORMP
|
$ 2.46
|
$ 99.2 M
|
$ -36 M
|
5.2
|
∙ |
$ 0.4
|
|
|
Yunhong International
ZGYH
|
$ 10.31
|
$ 92.2 M
|
$ 23.7 M
|
∙ |
∙ |
∙ |
|
|
Osmotica Pharmaceuticals plc
OSMT
|
$ 1.08
|
$ 89.9 M
|
$ 488 M
|
∙ |
∙ |
∙ |
|
|
vTv Therapeutics
VTVT
|
$ 26.97
|
$ 81.2 M
|
$ -23.5 M
|
∙ |
∙ |
∙ |
|
|
Chimerix
CMRX
|
$ 0.9
|
$ 79.7 M
|
$ -60.6 M
|
0.5
|
2.6
|
$ 2.0
|
|
|
Protalix BioTherapeutics
PLX
|
$ 1.15
|
$ 77.6 M
|
$ -11.1 M
|
10.9
|
1.1
|
$ 0.1
|
|
|
BioXcel Therapeutics
BTAI
|
$ 2.63
|
$ 76.6 M
|
$ -176 M
|
∙ |
∙ |
∙ |
|
|
Marinus Pharmaceuticals
MRNS
|
$ 1.41
|
$ 75.8 M
|
$ -116 M
|
160.2
|
9.6
|
$ 0.0
|
|
|
Tiziana Life Sciences PLC
TLSA
|
$ 0.78
|
$ 71.5 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Entera Bio Ltd.
ENTX
|
$ 1.98
|
$ 70.3 M
|
$ -8.21 M
|
2.5
|
150.8
|
$ 0.5
|
|
|
CEL-SCI Corporation
CVM
|
$ 1.44
|
$ 68.3 M
|
$ -28.5 M
|
∙ |
∙ |
∙ |
|
|
Champions Oncology
CSBR
|
$ 5.02
|
$ 68 M
|
$ -1.78 M
|
∙ |
∙ |
∙ |
|
|
Odonate Therapeutics, Inc.
ODT
|
$ 1.52
|
$ 58.5 M
|
$ 275 M
|
∙ |
∙ |
∙ |
|
|
ARCA biopharma
ABIO
|
$ 3.58
|
$ 51.6 M
|
$ -10 M
|
∙ |
∙ |
∙ |
|
|
Cleveland BioLabs, Inc.
CBLI
|
$ 3.17
|
$ 49 M
|
$ -82.1 M
|
∙ |
∙ |
∙ |
|
|
Kazia Therapeutics Limited
KZIA
|
$ 0.37
|
$ 49 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Enochian Biosciences
ENOB
|
$ 0.7
|
$ 40.5 M
|
$ -21.5 M
|
∙ |
∙ |
∙ |
|
|
Auris Medical Holding Ltd.
EARS
|
$ 3.04
|
$ 39.2 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Evofem Biosciences
EVFM
|
$ 0.8
|
$ 38.1 M
|
$ -73.9 M
|
0.0
|
0.3
|
$ 143.8
|
|
|
AzurRx BioPharma, Inc.
AZRX
|
$ 3.45
|
$ 34.4 M
|
∙ |
∙ |
∙ |
∙ |
|
|
VistaGen Therapeutics
VTGN
|
$ 4.75
|
$ 34 M
|
$ -53.8 M
|
∙ |
∙ |
∙ |
|
|
Pluristem Therapeutics
PSTI
|
$ 1.03
|
$ 33.3 M
|
$ -32.2 M
|
∙ |
∙ |
∙ |
|
|
Orphazyme A/S
ORPH
|
$ 0.87
|
$ 31.3 M
|
$ 17.6 M
|
∙ |
∙ |
∙ |
|
|
Seneca Biopharma, Inc.
SNCA
|
$ 1.66
|
$ 28.7 M
|
$ 214 M
|
∙ |
∙ |
∙ |
|
|
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
$ 4.37
|
$ 28.1 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Evogene Ltd.
EVGN
|
$ 0.63
|
$ 27.9 M
|
∙ |
∙ |
∙ |
∙ |
|
|
ERYTECH Pharma S.A.
ERYP
|
$ 0.78
|
$ 27.7 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Midatech Pharma plc
MTP
|
$ 0.29
|
$ 27.3 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Eyenovia
EYEN
|
$ 0.63
|
$ 25.9 M
|
$ -26.5 M
|
∙ |
∙ |
∙ |
|
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
$ 1.95
|
$ 24.7 M
|
$ 302 M
|
∙ |
∙ |
∙ |
|
|
Sol-Gel Technologies Ltd.
SLGL
|
$ 0.89
|
$ 24.1 M
|
$ -28.2 M
|
3.3
|
10.7
|
$ 1.3
|
|
|
Stealth BioTherapeutics Corp
MITO
|
$ 0.32
|
$ 23.9 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Immuron Limited
IMRN
|
$ 2.64
|
$ 22.9 M
|
∙ |
∙ |
∙ |
∙ |
|
|
iBio
IBIO
|
$ 1.76
|
$ 21.6 M
|
$ -26.1 M
|
∙ |
∙ |
∙ |
|
|
Palatin Technologies
PTN
|
$ 1.82
|
$ 21.2 M
|
$ -34.5 M
|
∙ |
∙ |
∙ |
|
|
MEI Pharma
MEIP
|
$ 3.05
|
$ 20.3 M
|
$ 34.4 M
|
∙ |
∙ |
∙ |
|
|
Millendo Therapeutics, Inc.
MLND
|
$ 1.06
|
$ 20.2 M
|
$ 1.05 B
|
∙ |
∙ |
∙ |
|
|
Forward Pharma A/S
FWP
|
$ 2.64
|
$ 18.7 M
|
∙ |
∙ |
∙ |
∙ |
|
|
BiomX
PHGE
|
$ 0.35
|
$ 18 M
|
$ -26.3 M
|
0.6
|
∙ |
$ 0.7
|
|
|
Intec Pharma Ltd
NTEC
|
$ 9.63
|
$ 17.7 M
|
$ 305 M
|
∙ |
∙ |
∙ |
|
|
BioVie
BIVI
|
$ 0.48
|
$ 15.6 M
|
$ -44.8 M
|
∙ |
∙ |
∙ |
|
|
Kala Pharmaceuticals
KALA
|
$ 6.3
|
$ 15.3 M
|
$ -82.1 M
|
1.2
|
∙ |
$ 4.6
|
|
|
Orgenesis
ORGS
|
$ 0.5
|
$ 14.5 M
|
$ -16.7 M
|
0.7
|
0.6
|
$ 0.8
|
|
|
IMV
IMV
|
$ 0.82
|
$ 13.1 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Aptorum Group Limited
APM
|
$ 3.14
|
$ 13.1 M
|
∙ |
∙ |
∙ |
∙ |
|
|
NanoViricides
NNVC
|
$ 1.12
|
$ 13 M
|
$ -7.12 M
|
∙ |
∙ |
∙ |
|
|
Cellect Biotechnology Ltd.
APOP
|
$ 13.17
|
$ 12.9 M
|
$ 170 M
|
∙ |
∙ |
∙ |
|
|
Celyad Oncology SA
CYAD
|
$ 0.47
|
$ 12.5 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Vascular Biogenics Ltd.
VBLT
|
$ 0.16
|
$ 12.4 M
|
$ -35.6 M
|
0.0
|
∙ |
$ 4.6
|
|
|
Aridis Pharmaceuticals
ARDS
|
$ 0.31
|
$ 11.1 M
|
$ -22.9 M
|
∙ |
4.9
|
∙ |
|
|
Edesa Biotech
EDSA
|
$ 4.42
|
$ 10.5 M
|
$ -8.58 M
|
∙ |
∙ |
∙ |
|
|
Aytu BioScience
AYTU
|
$ 2.9
|
$ 9.69 M
|
$ -8.28 M
|
∙ |
∙ |
∙ |
|
|
Benitec Biopharma
BNTC
|
$ 6.9
|
$ 9.56 M
|
$ -22.6 M
|
∙ |
∙ |
∙ |
|
|
ASLAN Pharmaceuticals Limited
ASLN
|
$ 0.42
|
$ 9.36 M
|
∙ |
∙ |
∙ |
∙ |
|
|
Monopar Therapeutics
MNPR
|
$ 0.66
|
$ 9.12 M
|
$ -9.33 M
|
∙ |
∙ |
∙ |
|
|
Cyclerion Therapeutics
CYCN
|
$ 2.93
|
$ 6.85 M
|
$ -41.6 M
|
∙ |
∙ |
∙ |
|
|
PolyPid Ltd.
PYPD
|
$ 4.75
|
$ 6.67 M
|
$ -17.9 M
|
0.0
|
∙ |
$ 25.9
|
|
|
Titan Pharmaceuticals
TTNP
|
$ 6.77
|
$ 5.09 M
|
$ -8.97 M
|
∙ |
21.4
|
∙ |
|
|
Gamida Cell Ltd.
GMDA
|
$ 0.03
|
$ 5.04 M
|
$ -73.5 M
|
1.2
|
∙ |
$ 1.4
|
|
|
Artelo Biosciences
ARTL
|
$ 1.34
|
$ 4.27 M
|
$ -9.36 M
|
∙ |
∙ |
∙ |
|
|
Sonnet BioTherapeutics Holdings
SONN
|
$ 1.77
|
$ 1.84 M
|
$ -37 M
|
∙ |
∙ |
∙ |
|
|
Galmed Pharmaceuticals Ltd.
GLMD
|
$ 0.39
|
$ 1.08 M
|
$ -10.5 M
|
0.5
|
23.3
|
$ 1.0
|
|
|
Tenax Therapeutics
TENX
|
$ 3.48
|
$ 1.04 M
|
$ 7.82 M
|
∙ |
∙ |
∙ |
|
|
InMed Pharmaceuticals
INM
|
$ 0.23
|
$ 563 K
|
$ -13 M
|
∙ |
∙ |
∙ |
|
|
Enanta Pharmaceuticals
ENTA
|
$ 12.37
|
$ 259 K
|
$ -191 M
|
∙ |
∙ |
∙ |
|